Characteristics of various immunochemical forms of multiple myeloma in relation to mortality and response to treatment
Mokeeva, R.A.; Khokhlova, M.P.; Kozinets, G.I.; Zhuravlev, V.S.; Rybakova, M.E.
Gematologiia i Transfuziologiia 31(7): 7-13
1986
ISSN/ISBN: 0234-5730 PMID: 3744018 Document Number: 279367
Document emailed within 1 workday
Related Documents
Clavio, M.; Casciaro, S.; Gatti, A.M.; Spriano, M.; Bonanni, F.; Poggi, A.; Vallebella, E.; Pietrasanta, D.; Prencipe, E.; Goretti, R.; Vimercati, R.; Rossi, E.; Masoudi, B.; Ghio, R.; Boccaccio, P.; Ricciardi, S.; Damasio, E.; Gobbi, M. 1996: Multiple myeloma in the elderly: clinical features and response to treatment in 113 patients Haematologica 81(3): 238-244Alberts, D.S.; Durie, B.G.; Salmon, S.E. 1977: Treatment of multiple myeloma in remission with anticancer drugs having cell cycle specific characteristics Cancer Treatment Reports 61(3): 381-388
Dogaru, M.; Lazăr, V.; Coriu, D. 2012: Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases Roumanian Archives of Microbiology and Immunology 71(4): 183-200
Kashkin, K.P.; Surinov, B.P.; Bochkova, D.N. 1970: An immunochemical and electrophoretic study of multiple forms of esterases of carbonic acid esters in rats Biulleten' Eksperimental'noi Biologii i Meditsiny 69(6): 39-42
Hrncír, Z.; Tichý, M.; Mazák, J.; Matĕja, F.; Hrncírová, L.; Mracek, J.; Rovenský, J. 1975: Paraprotein in a sample of 340 individuals. Relation of immunochemical characteristics to age and sex Casopis Lekaru Ceskych 114(8): 227-231
Beĭlbaeva, M.L.; Sukhodoeva, G.S.; Darkanbaeva, E.T.; Shuratova, S.G.; Koval', G.P. 1980: Comparative immunochemical and immunoallergologic characteristics of staphylococci varying in pathogenicity. I. Immunochemical characteristics of the antigenic composition of S. aureus and S. epidermidis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 10: 44-47
Stevenson, F.K.; Sahota, S.S. 1999: B cell maturation in relation to multiple myeloma Pathologie-Biologie 47(2): 89-97
Patriarca, F.; Gaidano, G.; Capello, D.; Zaja, F.; Fanin, R.; Baccarani, M. 2000: Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation Haematologica 85(9): 982-985
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Rapazzini, P.; Bettini, R.; Masini, M.; Steidl, L.; Ferrari, V.; Piantanida, S. 1986: Therapy of multiple myeloma and monitoring of the response Recenti Progressi in Medicina 77(2): 95-99
Scudla, V.; Papajík, T.; Bacovský, J.; Budíková, M.; Klímová, D. 1994: Serum thymidine kinase in multiple myeloma: II. Relation to disease activity and stage Vnitrni Lekarstvi 40(3): 157-162
Ludwig, H.; Fritz, E. 1982: Lymphocyte subpopulations in multiple myeloma. Shift in the helper/suppressor cell relation Acta Medica Austriaca 9(5-6): 215-220
Abdulkadyrov, K.M.; Bessmel'tsev, S.S. 1995: The characteristics of the immunological indices in multiple myeloma during polychemotherapy Likars'ka Sprava 1995(3-4): 75-80
Riccardi, A.; Montecucco, C.; Merlini, G.; Ucci, G.; Cremonini, N.; Gobbi, P.G.; Ascari, E. 1984: Proliferative activity, response to therapy and survival in multiple myeloma Haematologica 69(2): 148-162
Hartman, H.A.; Skoog, D.; Foley, J.F.; Stone, D.B. 1979: Response to adriamycin and CCNU in a patient with IgD multiple myeloma and myelofibrosis Nebraska Medical Journal 64(7): 201-205
Zdziarska, B. 1990: Retrospective analysis of patients with multiple myeloma; clinical characteristics and prognostic factors Annales Academiae Medicae Stetinensis 36: 179-194
Scudla, V.; Budíková, M.; Bacovský, J.; Opíchalová, D.; Farbiaková, V. 2000: Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma Casopis Lekaru Ceskych 139(13): 401-406
Golenkov, A.K.; Trifonova, E.V.; Kataeva, E.V.; Kil'diushevskiĭ, A.V.; Lutskaia, T.D.; Zariad'eva, E.A.; Nazarova, I.N.; Lukashina, M.N.; Zabotina, T.N.; Mikhaĭlova, I.N.; Inshakov, A.N.; Logacheva, N.P.; Baryshnikov, A.Iu. 2000: Characteristics of drug resistance of tumor plasmocytes in vitro in patients with multiple myeloma differently responsive to chemotherapy Terapevticheskii Arkhiv 72(8): 38-41
Brouet, J.C. 1993: Treatment of multiple myeloma La Revue du Praticien 43(3): 321-325